The present study is therefore the first to report that CUL4B is an anti-apoptosis molecule, which occurs partially through activation of the ERK signaling pathway and phosphorylation of FOXO3A in lung cancer (the whole pathway is summarized in Figure 8). Here, CUL4B is linked to lung cancer.